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Abstract
Background: Asthma is a chronic disease affecting 30 million people in Europe under 45y. Poor control of Asthma
is the main cause of emergency-department (ED) access, becoming the strongest determinant of the economic
burden of asthma management.
Objective: To examine the characteristics of adult patients admitted to ED for acute asthma attack, focusing on
previous diagnosis of asthma (DA) and current therapy.
Methods: During a one-year period, a structured questionnaire, assessing asthma diagnosis and management, was
administered to all patients admitted for asthma attack, to the ED of a South-Italy town. Only patients with
subsequently confirmed asthma were enrolled.
The data on oxygen saturation (Sat.O2), heart and respiratory-rate, severity code ED-admission, hospitalization or
discharge, had been obtained.
Results: Two hundred one patients (mean 50.3ys), were enrolled. One hundred eighteen had a DA, made 17.5 ±
5.88 years before, and 35.6% had a specialist-examination in the last year. 53.3% of DA-patients used a self-
medication before ED access with short-acting-beta-2-agonist and oral-corticosteroids, although none had a
written-asthma-action-plan (WAAP). Almost all DA-patients were on regular therapy: inhaled-corticosteroids (ICS) in
61%, associated with LABA in 85%. 16.7% of DA-patients had previous DA-access. The overall hospitalization-rate
was 39%, higher in DA compared to unknown asthmatic patients (UA)(p = 0.017).
Significant risk factors for hospitalization were Sat-O2 ≤ 94% breathing ambient air (OR9.91, p < 0.001), inability-to-
complete a sentence (OR9.42,p < 0.001) and the age (OR1.02,p = 0.049).
Conclusion: Despite the asthma guidelines-recommendation, up to 40% of patients received the asthma diagnosis
in ED, only 61% of DA-patients were taking ICS. It is disappointing that DA-patients did not have a WAAP, which
could explain the poor patient-self-medication at ED admission.
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Background
Asthma is an important public health problem in Eur-
ope, affecting around 30 million children and adults
under 45 years of age [1]. Estimates indicate that the age
standardized hospital admission rate for asthma ranges
from 30 to 70 per 100.000 Europeans older than 15
years, with an estimated economic burden of € 19.5 bil-
lion annually [1, 2]. The lack of disease control has been
reported to be the strongest determinant of the individ-
ual total cost, which was 3-fold higher among uncon-
trolled subjects compared to controlled/partly controlled
individuals, due to the increase in the indirect and hos-
pital costs [3, 4]. Emergency department visits impose a
heavy economic burden on health care, as each emergency
visit costs 5-fold more than outpatient visits for asthma
[5]. Unfortunately, epidemiological surveys suggest that
the control of asthma is still poor in the general popula-
tion, mainly due to under-treatment of the disease [6–8].
Most emergency department (ED) visits for acute
asthma are thought to be preventable [9], considering
that the management of ED frequent attenders was
found suboptimal according to guidelines [10].
Despite the heavy economic burden of asthma-related
ED visits, few studies have been designed to characterize
the asthmatic patients who attend ED for acute asthma. Ac-
cording to a large epidemiological study, primarily focused
on the quality of emergency asthma care, the proportion of
asthmatic patients taking inhaled corticosteroids as long-
term control medication was only 35% [11] and although
the guidelines recommend the prescription of written
asthma action plans (WAAP), their use remains limited
[12, 13]. The aim of the study was to examine the patient
characteristics of adult patients admitted to the Emergency
Department of Dimiccoli Hospital (the general hospital of
Barletta, a 90,000 inhabitants town of South Italy) for an
acute asthma attack, focusing on previous diagnosis of
asthma and current asthma therapy.
Methods
All patients (age ≥ 12 and < 65 years) admitted to the ED
for suspected acute asthma attack (ICD-9-CM 2012
Diagnosis Code: 493 as primary diagnosis) since 1st
January 2013 until 31st December 2013 signed an in-
formed consent form to participate in this study, which
had been approved by the Local Ethic Committee.
A questionnaire was administered to all enrolled pa-
tients to obtain information about previous physician di-
agnosed asthma (DA) and current asthma medications,
allergic rhinitis, outpatient visits for asthma and spirom-
etry performed in the last 12 months, previous ED visits
for asthma attack in the last 12 months, details of the
medication used for asthma attack and whether the
patients had received a written asthma action plan
(WAAP) and comorbidities including allergic rhinitis
were also assessed (Additional file 1). The duration of
symptoms before the ED access was also considered. In this
regard, the time lapse between the onset of the asthma at-
tack and the ED attendance has been partitioned up to 6 h,
6 to 24 h and more than 24 h. Patients who had not previ-
ously received a diagnosis of asthma or who were not tak-
ing any medication for asthma, including inhalers, aerosol
or tablets, were classified as possible unknown asthma.
Every possible unknown asthmatic enrolled was evaluated
by an Allergist/Pneumologist in the following months and
was included in the final study population only if the diag-
nosis of asthma had been confirmed, according to GINA
guidelines. These patients have been classified as “Un-
known Asthma” (UA) at the ED admission.
Data on oxygen saturation, heart and respiratory rate,
severity code admission at ED, ED course, and ED dis-
position about hospitalization or discharge, were ob-
tained by chart review.
Statistical analysis was performed using a commercially
available statistical package Stata 13.1 (Stata Corp LP, Col-
lege Station, TX, USA), considering statistically significant
only p values < 0.05. Data are given as means ± SD.
Three normality tests were performed (Kolmogorov-
Smirnov, Shapiro-Wilk and D’Agostino‘s K-squared), to
establish the distribution of the data. Basing on the normal
or not normal distribution, the comparisons between clin-
ical data from UA and DA patients, were performed using
Student’s t-test or Mann-Whitney U test.
The factors associated with a patient’s admission were
assessed with the use of logistic regression analysis. All
factors associated with p < 0.10 on univariable analysis
were included in the multivariate model. All tests were
two-sided, and variables were considered significant for
p-values < 0.05.
Results
Two hundred one patients had been admitted to the ED
in 12 months, 126 (62.7%) male and 75 (37.3%) female,
with a mean age 50.3 years (range 12–65 yrs).
Of all the patients who were included, there were 118
(58.7%) with DA and 83 (41.3%) with UA. Clinical and
demographic characteristics of the two groups are re-
ported in Table 1.
In the group of DA patients, the diagnosis had been
made 17,5 (95%CI 14.8–19.9) years before, and 42 out of
118 (35.6%) had a specialist examination in the last 12
months. Allergic rhinitis was reported by 54.2% of patients
with DA and by 6% of patients with UA (p < 0.001). Con-
cerning the time lapse between the onset of asthma attack
and the ED access, a greater prevalence of ED access be-
tween the 6th and 24th hour was observed in DA patients
(62.7%) compared to UA patients (44.6%, p = 0.011), while
no differences were observed in early access (< 6 h),
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respectively 21,2 and 30,2%, and in late access (> 24 h), re-
spectively 12.7 and 20.5%.
Sixty-three DA patients (53.3% of all DA patients)
used self-medication before the ED access, consisting of
short-acting beta-2 agonist (SABA) in 57 of them (90%)
and oral corticosteroids in 6 (10%), according to their
physicians’ advice. No patient had a WAAP and none
used peak flow assessment.
Almost all the DA patients (112/118, 94.9%) were on
regular therapy, consisting of inhaled corticosteroids
(ICS) in 68/112 (60.71%), associated with LABA in 85%
of them, SABA alone in 14 patients (12.5%), antihista-
mines for associated allergic rhinitis in 25 (22%), oral
corticosteroids (OCS) in 4 (3,5%) and theophylline in
one patient (0,9%).
Twenty DA patients (16.9%) had an history of previous
ED access during the last 12 months. Among these pa-
tients, 14 (70%) had at least one specialist examination
in the last 12 months, 18 (90%) received regular treat-
ment with ICS, combined with LABA in 78%, while two
patients (10%) were taking only antihistamine drugs for
concomitant rhinitis.
The hospitalization rate after acute admission in ED
was 38.8% (78/201) for the whole study population,
significantly higher in DA compared to UA patients (64
and 36% respectively, p = 0.017).
Clinical and demographic characteristics of hospital-
ized patients (HP) compared to patients who were dis-
charged are reported in Table 2. Patients who were
hospitalized were older (60.8 vs 43.5 yrs., p < 0.001), had
higher prevalence of previous diagnosis of asthma (64.1
vs 55%, p = 0.009) and previous ED visits (16.7% vs
11.4%, p = 0.01), lower SaO2 (89.8 vs 96.1%, p < 0.001),
higher respiratory rate (22 ± 4 vs 18.5 ± 2.8, p < 0.001)
and pulse rate (85.4 ± 15 vs 80.3 ± 13, p = 0.004), and
they were more frequently unable to complete a sen-
tence (67.95 vs 13.8%, p < 0.001).
Multivariate analysis (Table 3) showed that independ-
ent significant risk factors for hospitalization were oxy-
gen saturation lower than 94% at breathing air (OR 9.91,
p < 0.0001), the inability to complete a sentence (OR
9.42, p < 0.0001) and the age of the patients (OR 1.02,
p = 0.049).
Discussion
A surprising result of our study was that 40% of patients
presenting to the ED received the diagnosis of asthma
for the first time. It is known that asthma may be
Table 1 - Clinical and demographic characteristics of the enrolled patients with previously diagnosed (DA) and not previously
known (UA) asthma
Characteristics DA n = 118 UA n = 83 p
Male % 61 65 ns
Mean age (range) 50.3 (12–64) 46.4 (12–65) ns
Specialist examination in the last 12 months n (%) 42 (35.6) –
Rhinitis n (%) 64 (54,2) 5 (6) p < 0.001
Male %: percentage of male enrolled to the study. Mean age (range): mean age of people enrolled to the study. Specialist examination in the last 12 months:
number of people who consulted a specialist in the last 12months. Rhinitis n (%): percentage of people affected by rhinitis
Table 2 – Risk factors determining the hospitalization (201 patients)
Hospitalized patients
(n 78)
Discharged patients (n 123) p =
Age - years (range) 60.8 (12–65) 43.5 (12–63) < 0.001
DA (%) 64.1 55 0.009
≥1 ED admission (%) 16.7 11.4 0.010
SaO2% (SD) 89.8 (8.09) 96.1 (2.74) < 0.001
Respiratory rate (SD) 22 (3.97) 18.53 (2.76) < 0.001
Pulse rate (SD) 85.4 (15.01) 80.33 (13.04) 0.004
Years from diagnosis (SD) 14.53 (5.88) 7.41 (11.26) Ns
ED admission code (%) Green 15.4%
Yellow 64.1%
Red 20.5%
Green 57.7%
Yellow 42.3%
< 0.001
Inability to complete a sentence (%) 67.95 13.82 < 0.001
Age - yrs. (range): mean age of the two considered groups. DA (%): percentage of patients with previous asthma diagnosis. ≥1 ED admission (%): percentage of
patients with more than one ED admission in the last 12 months. SaO2% (SD): mean pulse oximetry at ED visit. Respiratory rate (SD): mean values of respiratory
rate at ED visit. Pulse rate (SD): mean values of pulse rate at ED visit. Years from diagnosis (SD): numbers of years since the diagnosis of asthma. ED admission
code (%): index of disease severity (green: low severity; yellow: medium severity; red: emergency). Inability to complete a sentence (%): percentage of people who
could not complete a sentence due to dyspnea
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diagnosed for the first time in a patient presenting to the
ED, but, in the majority of cases, the patient will be
aware of the underlying diagnosis of asthma [14].
A confident diagnosis of asthma cannot be made on a
single visit to the ED, (particularly in children and in
older patients, who were not enrolled in our study) and
the mis-diagnosis of asthma is also frequent in patients
managed in primary care settings [15, 16]. Many condi-
tions that may mimic asthma acutely had been consid-
ered and excluded in our patients, such as pulmonary
embolism, heart failure or hyperventilation syndrome. In
all these patients the diagnosis of asthma was confirmed
by a specialist during the follow-up visits after Hospital
discharge. It appears that, for many patients, asthmatic
symptoms are not considered serious enough to be re-
ported to their general practitioner, until an acute
asthma attack occurs, which forces them to go to the
emergency department. The only difference between pa-
tients with UA compared to patients with DA was the
prevalence of rhinitis, which was reported only in 6% of
the UA patients compared to 54% of DA. Rhinitis co-
morbidity may lead the patients with asthmatic symp-
toms to be evaluated by their physicians for asthmatic
symptoms earlier than the patients without rhinitis.
Inhaled corticosteroids were regularly used by 60% of
our patients with DA, a percentage higher than the per-
centage previously reported in patients admitted to ED
for asthma, which had been reported as low as 35% in a
US large epidemiological study primarily focused on the
quality of emergency asthma care during exacerbation
[11]. Indeed, despite an increase in the consumption of
inhaled corticosteroids (ICS), their use is still inadequate,
since five out of 10 asthmatic patients were using a
medication regimen below their disease severity level,
according to an Italian epidemiologic study and the in-
adequate dosing of ICS was found to be the main
predictor of the poor control of the disease in the same
study [6].
High use of health services, including ED visits, has
been observed in patients with suboptimal asthma drug
regimens in a Canadian population-based assessment
study [17]. In particular, adolescents with suboptimal regi-
mens were the most likely to have hospital admissions
(odds ratio (OR) 3.8; 95% confidence interval (CI) 1.8–
7.8), visit the ED (OR 2.2; 95% CI 1.6–3.1) and be high
users of family physician services (OR 5.7; 95% CI 4.0–8.1)
compared with patients in other age groups. Recently the
diagnosis of asthma has been reported in 12.7% of patients
who presented to an Emergency Department in the Asia
Pacific region with a principal symptom of dyspnea [18].
Over 90% of these patients had received a previous diag-
nosis of asthma, but only 40% of them used inhaled corti-
costeroids as regular treatment. In our study, up to 90% of
the patients who had been previously admitted to ED for
asthma exacerbation used ICS and most of them had had
a specialist visit for their asthma in the last 12months,
compared to only 35% of the other patients. In our pa-
tients the reasons for frequently attending ED seemed to
be found in the severity of asthma and not in socioeco-
nomic factors, as reported in a US study [19]. It is disap-
pointing that no patient with DA had a written asthma
action plan for managing asthma exacerbation. This ex-
plains why only 60% of the patients used self-administered
medication before their admission at ED.
In conclusion, despite guideline recommendations about
asthma diagnosis and treatment, up to 40% of patients
presenting to the ED received the diagnosis of asthma for
the first time, and ICS were regularly used only by 60% of
patients with known asthma. Moreover, it is disappointing
that none of the patients had a WAAP. This could explain
why only 53% of the patients used self- administered
medication before their attendance at the ED.
Conclusions
Despite asthma guidelines-recommendation, up to 40%
of patients received the asthma diagnosis in ED, only
61% of DA-patients were taking ICS. It is disappointing
that DA-patients did not have a WAAP, which could ex-
plain the poor patient-self-medication at ED admission.
Additional file
Additional file 1: “Asthma questionnaire – Emergency Department
admission due to asthma attack” Description of data: the questionnaire
contains data assessing asthma diagnosis and management, primary vital
signs and drugs administered in Emergency Department (ED) in patients
admitted to the ED for an acute asthma attack. (DOCX 15 kb)
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Table 3 - Multivariate analysis of risk factor affecting the
hospitalization (193 Patients)
Variable Odd Ratio [95%CI] p =
Age 1.02 [1.01–1.05] 0.049
Years from diagnosis (SD) 1.00 [0.97–1.05] ns
Time lapse< 6 h 0.80 [0.28–2.33] ns
6–24 h 0.81 [0.29–2.31] ns
> 24 h 1.2 [0.31–4.74] ns
SaO2≤ 94 9.91 [3.83–25.6] < 0.0001
Respiratory rate≥ 18/min 2.99 [0.78–11.5] ns
Inability to complete a sentence 9.42 [3.60–24.7] < 0.0001
Age: mean age of patients hospitalized or not. Lenght from Diagnosis: years
since diagnosis of asthma. Time lapse < 6 h: less than 6 h between symptoms
onset and ED admission. 6–24 h: 6 to 24 h between symptoms onset and ED
admission. > 24 h: more than 24 h between symptoms onset and ED
admission. SaO2 < =94: pulse oximetry at ED visit less than 94% on air (FiO2
21%). Respiratory rate ≥ 18/min: respiratory rate more than 18 acts per minute
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ICS: Inhaled-Corticosteroids; LABA: Long Acting Beta 2 Agonists; OR: Odd
Ratio; SABA: Short-Acting Beta-2 Agonist; Sat.O2: Oxygen Saturation;
UA: Undiagnosed Asthma; WAAP: Written-Asthma-Action-Plan
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